New early detection methods can mean significantly improved outcomes for patients. Our researchers are at the forefront of this ground-breaking work.

Did you know?

Heart disease has an enormous financial cost.

Comprising approximately 11% of the total health budget.

45,600 Australians died from cardiovascular disease in 2011.

Accounting for 31 per cent of all Australian deaths. 

In 2009-2010 cardiovascular disease was the main cause of 482,000 hospitalisations

 and played a secondary role in a further 800,000.

How our research is detecting heart disease

Early detection giving new hope

Our Clinical Research Group has developed a new early detection method for pulmonary vascular disease – or high blood pressure in the lungs – a severe condition affecting young adults.

Reversing the risk factor in babies with early interventions

While we know that the earliest changes of atherosclerosis can begin in children and teenagers, recent studies from our Clinical Research Group have shown that the origins of heart disease and vessel disease can begin even earlier – in the foetus. 

4-dimensional flow magnetic resonance imaging

Heart failure is generally only clinically apparent once the disease process is advanced, leaving the clinician with limited treatment options. The Cardiac Imaging Group is developing 4-dimensional flow magnetic resonance imaging (4D-flow MRI), technology that is set to revolutionise not just cardiac imaging, but the daily practice of cardiology.